The reluctance of parents to have their children vaccinatedhas been linked to the highest number of measles cases in the United States since 1996.
The reluctance of parents to have their children vaccinatedhas been linked to the highest number of measles cases in the United States since 1996.

Vaccination and autism: the link is still missing



Between January and July of this year there were more cases of measles in the United States reported to the Centres for Disease Control and Prevention in Atlanta, Georgia, then at any time since 1996. This is a worrying statistic, and all the more so since it is being attributed to parents refusing to have their children vaccinated because of fears of a link between vaccinations and autism. This is an issue that has been gaining momentum for many years and it is unlikely to go away any time soon. Moreover, the situation is not limited to the United States. Parents' worries have quickly spread to other countries.

The consensus among the medical fraternity is that all vaccination programmes should remain in place, and although health professionals continue to try to alleviate parents' fears, that does not appear to have had an effect. This could be disastrous if a solution is not found, public health officials warn. Measles is a barometer for other diseases that may follow in unvaccinated populations. A rise in the number of cases of mumps and rubella could follow the spike in measles cases, doctors say.

Any link between vaccinations and autism in children has never been scientifically proven. Yet, as some autism research groups are eager to point out, there has never been categorical evidence to disprove the link either. The foundation for the entire vaccine-autism debate rests on a scientific paper published in The Lancet in 1998, in which lead author Dr Andrew Wakefield suggested the possibility of a link between the MMR (Measles Mumps Rubella) vaccine and certain cases of autism in children.

The work carried out by Dr Wakefield has never been replicated and he has even been accused of scientific misconduct. Although overall a growing body of data supports the 'no link' camp, this is an issue that will not go away. In an attempt to allay public fears, manufacturers of the MMR vaccine in the United States reduced the level of mercury as an ingredient of the product. The change was instituted seven years ago and now appears to have had little effect on reducing incidence of autism. But it could be argued that by doing this the public became more suspicious about this vaccine. After all, why tamper with a product that you are claiming is completely safe?

The situation became further complicated when earlier this year a leading physician at the centre of health policy in the United States made a claim about the possible susceptibility of some children to autism from vaccine jabs. Dr Bernadine Healy, the ex-head of the US National Institutes of Health, in an interview with CBS in May, is quoted as saying: "What we are seeing is that, in the bulk of the population vaccines are safe, but there may be a susceptible group."

Dr Healy has suggested that studies being carried out might be missing crucial factors that may offer a possible link between vaccinations to autism in a small group of individuals. Or rather, because this type of research is being overlooked any link cannot be discounted. Indeed part of her claim is that as part of the research, the Institute of Medicine (IOM), as far back as 2004 was allegedly looking to avoid seeking patient groups who might be susceptible. The reason for this was put down to public safety concerns by the IOM.

Critics claimed that the institute feared that if the slightest suggestion of research offering a link between vaccinations and autism was revealed, the knock-on effect would be masses of parents refusing to have their children immunised, with serious consequences to long term public health. Although for some this might be construed as a legitimate reason, the outcome has backfired in spectacular fashion, at least in the United States. Elsewhere, vaccination programmes are administered as planned, including in the UAE.

Mohammad al Emadi, the Director General of the Dubai Autism Centre, feels a level of bemusement over the current situation in the United States. "We've noticed that the people who are talking about this are in America," he said. "Around the world this isn't happening. You can't really say that's the proof that causes autism. There have been exercises that have removed the vaccinations and still the cases of autism are there."

Mr Emadi indicated there is no single factor relating to why a child will become autistic, and there is continued research to explain its exact causes. "You can't say it's the environment, you cannot say it's genetic, you can't say it's because of a food allergy, or that it's a vaccination. It is multiple entries. Autism can come from anywhere," he said. "Each child has a different autism and they've got it from a different place. Some have got it from an infection in the ear; some have got a very high fever... You cannot say this is the cure and this is the problem," he concluded.

Mr Emadi believes that decisions can only be made once adequate research indicates the root causes of autism, echoing a view shared by the majority of policy-makers and medical professionals. Yet, as long as the debate continues to rage in the United States it could spread to other countries quickly. First and foremost, parents worry about the health of their children, and if there are any doubts about the safety of vaccines in the long term this will have a massive bearing on how successful that vaccination programme will be.

Whether it is in the United States or the UAE, a solution has to be found for the problem at hand: how to adequately provide a vaccination programme that protects children while alleviating the fears of the public. Peter Donnelly is a science correspondent with the Life Science Division of IIR Middle East.

Volvo ES90 Specs

Engine: Electric single motor (96kW), twin motor (106kW) and twin motor performance (106kW)

Power: 333hp, 449hp, 680hp

Torque: 480Nm, 670Nm, 870Nm

On sale: Later in 2025 or early 2026, depending on region

Price: Exact regional pricing TBA

2025 Fifa Club World Cup groups

Group A: Palmeiras, Porto, Al Ahly, Inter Miami.

Group B: Paris Saint-Germain, Atletico Madrid, Botafogo, Seattle.

Group C: Bayern Munich, Auckland City, Boca Juniors, Benfica.

Group D: Flamengo, ES Tunis, Chelsea, (Leon banned).

Group E: River Plate, Urawa, Monterrey, Inter Milan.

Group F: Fluminense, Borussia Dortmund, Ulsan, Mamelodi Sundowns.

Group G: Manchester City, Wydad, Al Ain, Juventus.

Group H: Real Madrid, Al Hilal, Pachuca, Salzburg.

COMPANY PROFILE

Company: Bidzi

● Started: 2024

● Founders: Akshay Dosaj and Asif Rashid

● Based: Dubai, UAE

● Industry: M&A

● Funding size: Bootstrapped

● No of employees: Nine

Mercer, the investment consulting arm of US services company Marsh & McLennan, expects its wealth division to at least double its assets under management (AUM) in the Middle East as wealth in the region continues to grow despite economic headwinds, a company official said.

Mercer Wealth, which globally has $160 billion in AUM, plans to boost its AUM in the region to $2-$3bn in the next 2-3 years from the present $1bn, said Yasir AbuShaban, a Dubai-based principal with Mercer Wealth.

Within the next two to three years, we are looking at reaching $2 to $3 billion as a conservative estimate and we do see an opportunity to do so,” said Mr AbuShaban.

Mercer does not directly make investments, but allocates clients’ money they have discretion to, to professional asset managers. They also provide advice to clients.

“We have buying power. We can negotiate on their (client’s) behalf with asset managers to provide them lower fees than they otherwise would have to get on their own,” he added.

Mercer Wealth’s clients include sovereign wealth funds, family offices, and insurance companies among others.

From its office in Dubai, Mercer also looks after Africa, India and Turkey, where they also see opportunity for growth.

Wealth creation in Middle East and Africa (MEA) grew 8.5 per cent to $8.1 trillion last year from $7.5tn in 2015, higher than last year’s global average of 6 per cent and the second-highest growth in a region after Asia-Pacific which grew 9.9 per cent, according to consultancy Boston Consulting Group (BCG). In the region, where wealth grew just 1.9 per cent in 2015 compared with 2014, a pickup in oil prices has helped in wealth generation.

BCG is forecasting MEA wealth will rise to $12tn by 2021, growing at an annual average of 8 per cent.

Drivers of wealth generation in the region will be split evenly between new wealth creation and growth of performance of existing assets, according to BCG.

Another general trend in the region is clients’ looking for a comprehensive approach to investing, according to Mr AbuShaban.

“Institutional investors or some of the families are seeing a slowdown in the available capital they have to invest and in that sense they are looking at optimizing the way they manage their portfolios and making sure they are not investing haphazardly and different parts of their investment are working together,” said Mr AbuShaban.

Some clients also have a higher appetite for risk, given the low interest-rate environment that does not provide enough yield for some institutional investors. These clients are keen to invest in illiquid assets, such as private equity and infrastructure.

“What we have seen is a desire for higher returns in what has been a low-return environment specifically in various fixed income or bonds,” he said.

“In this environment, we have seen a de facto increase in the risk that clients are taking in things like illiquid investments, private equity investments, infrastructure and private debt, those kind of investments were higher illiquidity results in incrementally higher returns.”

The Abu Dhabi Investment Authority, one of the largest sovereign wealth funds, said in its 2016 report that has gradually increased its exposure in direct private equity and private credit transactions, mainly in Asian markets and especially in China and India. The authority’s private equity department focused on structured equities owing to “their defensive characteristics.”

Key facilities
  • Olympic-size swimming pool with a split bulkhead for multi-use configurations, including water polo and 50m/25m training lanes
  • Premier League-standard football pitch
  • 400m Olympic running track
  • NBA-spec basketball court with auditorium
  • 600-seat auditorium
  • Spaces for historical and cultural exploration
  • An elevated football field that doubles as a helipad
  • Specialist robotics and science laboratories
  • AR and VR-enabled learning centres
  • Disruption Lab and Research Centre for developing entrepreneurial skills
How to apply for a drone permit
  • Individuals must register on UAE Drone app or website using their UAE Pass
  • Add all their personal details, including name, nationality, passport number, Emiratis ID, email and phone number
  • Upload the training certificate from a centre accredited by the GCAA
  • Submit their request
What are the regulations?
  • Fly it within visual line of sight
  • Never over populated areas
  • Ensure maximum flying height of 400 feet (122 metres) above ground level is not crossed
  • Users must avoid flying over restricted areas listed on the UAE Drone app
  • Only fly the drone during the day, and never at night
  • Should have a live feed of the drone flight
  • Drones must weigh 5 kg or less
The National's picks

4.35pm: Tilal Al Khalediah
5.10pm: Continous
5.45pm: Raging Torrent
6.20pm: West Acre
7pm: Flood Zone
7.40pm: Straight No Chaser
8.15pm: Romantic Warrior
8.50pm: Calandogan
9.30pm: Forever Young

Victims%20of%20the%202018%20Parkland%20school%20shooting
%3Cp%3EAlyssa%20Alhadeff%2C%2014%3C%2Fp%3E%0A%3Cp%3EScott%20Beigel%2C%2035%0D%3C%2Fp%3E%0A%3Cp%3EMartin%20Duque%2C%2014%3C%2Fp%3E%0A%3Cp%3ENicholas%20Dworet%2C%2017%3C%2Fp%3E%0A%3Cp%3EAaron%20Feis%2C%2037%3C%2Fp%3E%0A%3Cp%3EJaime%20Guttenberg%2C%2014%0D%3C%2Fp%3E%0A%3Cp%3EChris%20Hixon%2C%2049%0D%3C%2Fp%3E%0A%3Cp%3ELuke%20Hoyer%2C%2015%3C%2Fp%3E%0A%3Cp%3ECara%20Loughran%2C%2014%0D%3C%2Fp%3E%0A%3Cp%3EGina%20Montalto%2C%2014%0D%3C%2Fp%3E%0A%3Cp%3EJoaquin%20Oliver%2C%2017%0D%3C%2Fp%3E%0A%3Cp%3EAlaina%20Petty%2C%2014%0D%3C%2Fp%3E%0A%3Cp%3EMeadow%20Pollack%2C%2018%3C%2Fp%3E%0A%3Cp%3EHelena%20Ramsay%2C%2017%0D%3Cbr%3E%0D%3C%2Fp%3E%0A%3Cp%3EAlex%20Schachter%2C%2014%0D%3C%2Fp%3E%0A%3Cp%3ECarmen%20Schentrup%2C%2016%0D%3C%2Fp%3E%0A%3Cp%3EPeter%20Wang%2C%2015%3Cbr%3E%3C%2Fp%3E%0A